Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sotirios Tsimikas

Showing results (31-40 of 420) with videos related to

Pageof 42
Sort By:
Journal of Lipid Research|May 28, 2015
HDL-C, ABCA1-mediated cholesterol efflux, and lipoprotein(a): insights into a potential novel physiologic role of lipoprotein(a)Calvin Yeang, Sotirios Tsimikas
Journal of the American Society of Nephrology : JASN|June 1, 2002
Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosisWulf Palinski, Sotirios Tsimikas
Expert Review of Cardiovascular Therapy|March 31, 2012
Lipoprotein oxidation biomarkers for cardiovascular risk: what does the future hold?Adam Taleb, Sotirios Tsimikas
Atherosclerosis|September 10, 2019
The challenges of measuring Lp(a): A fight against Hydra?Florian Kronenberg, Sotirios Tsimikas
Journal of the American College of Cardiology|January 21, 2022
Lipoprotein(a) and CT Angiography: Novel Insights Into High-Risk Plaque ProgressionSotirios Tsimikas, Jagat Narula
Current Opinion in Lipidology|October 9, 2012
Emerging therapeutic agents to lower lipoprotein (a) levelsBrian Kolski, Sotirios Tsimikas
JACC. Basic to Translational Science|February 12, 2020
Ancient Remedy for a Modern Disease: Will Celastrol Become a Treatment for Aortic Valve Stenosis?Calvin Yeang, Sotirios Tsimikas
JACC. Cardiovascular Interventions|February 19, 2021
Glucose Control in Patients Undergoing PCI: What Is the Optimal HbA<sub>1c</sub> for Long-Term Outcomes?Sotirios Tsimikas, Harpreet S Bhatia
Circulation Research|February 1, 2019
Lipid-Lowering AgentsRobert A Hegele, Sotirios Tsimikas
Current Opinion in Lipidology|July 9, 2008
The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicitySotirios Tsimikas, Joseph L Witztum
Pageof 42

Showing results (31-40 of 420) with videos related to

Sort By:
Pageof 42
Journal of Lipid Research|May 28, 2015
HDL-C, ABCA1-mediated cholesterol efflux, and lipoprotein(a): insights into a potential novel physiologic role of lipoprotein(a)Calvin Yeang, Sotirios Tsimikas
Journal of the American Society of Nephrology : JASN|June 1, 2002
Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosisWulf Palinski, Sotirios Tsimikas
Expert Review of Cardiovascular Therapy|March 31, 2012
Lipoprotein oxidation biomarkers for cardiovascular risk: what does the future hold?Adam Taleb, Sotirios Tsimikas
Atherosclerosis|September 10, 2019
The challenges of measuring Lp(a): A fight against Hydra?Florian Kronenberg, Sotirios Tsimikas
Journal of the American College of Cardiology|January 21, 2022
Lipoprotein(a) and CT Angiography: Novel Insights Into High-Risk Plaque ProgressionSotirios Tsimikas, Jagat Narula
Current Opinion in Lipidology|October 9, 2012
Emerging therapeutic agents to lower lipoprotein (a) levelsBrian Kolski, Sotirios Tsimikas
JACC. Basic to Translational Science|February 12, 2020
Ancient Remedy for a Modern Disease: Will Celastrol Become a Treatment for Aortic Valve Stenosis?Calvin Yeang, Sotirios Tsimikas
JACC. Cardiovascular Interventions|February 19, 2021
Glucose Control in Patients Undergoing PCI: What Is the Optimal HbA<sub>1c</sub> for Long-Term Outcomes?Sotirios Tsimikas, Harpreet S Bhatia
Circulation Research|February 1, 2019
Lipid-Lowering AgentsRobert A Hegele, Sotirios Tsimikas
Current Opinion in Lipidology|July 9, 2008
The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicitySotirios Tsimikas, Joseph L Witztum
Pageof 42